Increased PGC-1α expression could improve dopaminergic neuronal viability and mitochondrial activity in in vivo and in vitro PD models (Mudò et al., 2012; Ferretta et al., 2014; Mäkelä et al., 2016). This evidence concerns the gene PPARGC1A and Parkinson disease.